DOI : 10.1055/s-00000041

Neuropediatrics

Issue S 01 · Volume 56 · October 2025 DOI: 10.1055/s-015-62321


NEP 50th Annual Meeting of the Society for Neuropediatrics, 2025
Bern, Switzerland, 02.–04.10.2025

Abstracts (HTML) Abstracts (PDF) List of Authors
  • A-151
    Goßrau, G.; May, S. N.; Höfer, B.; Albessard, E.; Bittigau, P.:

    Administrative Epidemiology and Treatment Patterns of Paediatric Migraine: Results from a Retrospective Claims Data Analysis

  • A-243
    Kogel, L.; Möhrle, C.; Göhringer, T.; Reichelt, S.; Bonfert, M.; Büttner-Kunert, J.:

    Cognitive Communication Disorders and Its Academic Consequences in Adolescents After TBI: A Single-Case Comparison

  • A-187
    Finter, J.; Nickel, M.; Schulz, A.:

    EEG Changes Prior to Onset of Epilepsy: A Potential Early Biomarker to Monitor Disease Progression in CLN3 Disease

  • A-158
    Jung, S.; Klepper, S.; Gessner, A.; Neubert, A.; Trollmann, R.:

    Effects of C1 Esterase Inhibitor on Lipid Metabolomic Biomarkers in Hypoxic Neonatal Mice

  • A-122
    Huber, A.; Neul, J.; Percy, A.; Benke, T.; Berry-Kravis, E.; Glaze, D.; Marsh, E.; Bishop, K.; Youakim, J.:

    Efficacy and Safety of Trofinetide for the Treatment of Rett Syndrome: Results from the Pivotal Phase 3 LAVENDER Study

  • A-138
    Hershey, A. D.; Szperka, C. L.; Bittigau, P.; Barash, S.; Garnett, S.; Bryson, J.; Kessler, Y.; Erez, T.; Schwartz, Y. Carmeli; Grozinski-Wolff, M.; Ning, X.:

    Efficacy Outcomes from a Phase 3, Randomised, Double-Blind, Placebo-Controlled Study of Fremanezumab for the Preventive Treatment of Episodic Migraine in Children and Adolescents

  • A-184
    Horacek, L.; Börner-Schröder, C.; Hiendl, M.; Höss, A.; Reichert, M.; Schramm, S.; Zimmer, C.; Heinen, F.; Sollmann, N.; Bonfert, M.:

    Exploring Neuromuscular Mechanisms of Repetitive Neuromuscular Magnetic Stimulation: A Randomized, Sham-Controlled Study in Healthy Controls

  • A-137
    Reichelt, S.; Leonie, K.; Demmler, K.; Häfele, A.; Konrad, J.; Wagner, J.; Ritter, R.; Bonfert, M.; Büttner-Kunert, J.:

    From Setbacks to Outlooks: Cognitive-Linguistic Outcomes Following Pediatric TBI: A Scoping Review

  • A-272
    Kielkopf, M. C.; Gluscevic, S.; Gschaidmeier, A.; Bria, A.; Hess, H.; Monschein, T.; Goeschl, S.; Semerano, A.; Weber, P.; Wieske, M.; Jung, S.; Bassetti, C. L.:

    From Theory to Action: Raising Awareness for Brain Health Through the #BrainHealthChallenge2025

  • A-126
    Schupp, S.; Wagner, J.; Konrad, J.; Schönberg, N. K. T.; Bonfert, M. V.:

    How Postural Patterns Change After a Concussion: A Spectral Analysis Approach to Postural Control in Pediatric Patients Throughout Their Recovery from Mild Traumatic Brain Injury

  • A-173
    Sigel, H.; Johannsen, J.; Hüting, C.; Towhidi, S.; Denecke, J.; Bley, A.:

    Leukencephalopathy with Calcifications and Cysts: A Case Report of Clinical Improvement with Tiapride

  • A-150
    Hershey, A. D.; Szperka, C. L.; Bittigau, P.; Barash, S.; Garnett, S.; Bryson, J.; Kessler, Y.; Erez, T.; Schwartz, Y. Carmeli; Grozinski-Wolff, M.; Ning, X.:

    Safety Outcomes from a Phase 3, Randomised, Double-Blind, Placebo-Controlled Study of Fremanezumab for the Preventive Treatment of Episodic Migraine in Children and Adolescents

  • A-147
    Vaassen, P.; Simon, T.; Decarolis, B.; Wimmer, K.; Schamschula, E.; Draheim, P.; Wormland, B.; Rosenbaum, T.:

    Somatic KRASG12V-Variant as a Driver for Localized Hypertrophic Neuropathy Mimicking Plexiform Neurofibroma

  • A-201
    Huber, A.; Percy, A.; Neul, J.; Benke, T.; Berry-Kravis, E.; Glaze, D.; Marsh, E.; Bishop, K.; Youakim, J.:

    Trofinetide for the Treatment of Rett Syndrome: Long-Term Safety and Efficacy Results from the Open-Label LILAC and LILAC-2 Studies

  • A-246
    Magg, J.; Bevot, A.; Kehrer, M.; Rosewich, H.:

    UBR5-Associated Neurodevelopmental Disorder with Global Developmental Delay and Multi-Organ Involvement: A Case Report

  • A-222
    Büttner-Kunert, J.; Bonfert, M. V.; Reiner, J.:

    What Goals and Needs do Adolescents and Young Adults Identify for Rehabilitation After Traumatic Brain Injury? A Quantitative Online Survey